Ergoteles LLC Nevro Corp Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $1.65 Million - $2.15 Million	40,491 Added 483.07%	48,873 $2.28 Million
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $401,432 - $763,263	-9,827 Reduced 53.97%	8,382 $367,000
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $729,291 - $1.12 Million	12,165 Added 201.27%	18,209 $1.32 Million
Q4 2021 Feb 14, 2022	SELL	$81.07 - $121.29 $1.05 Million - $1.57 Million	-12,936 Reduced 68.16%	6,044 $490,000
Q3 2021 Nov 15, 2021	BUY	$101.99 - $166.36 $996,748 - $1.63 Million	9,773 Added 106.15%	18,980 $2.21 Million
Q2 2021 Aug 12, 2021	BUY	$141.6 - $179.06 $963,871 - $1.22 Million	6,807 Added 283.63%	9,207 $1.53 Million
Q1 2021 May 12, 2021	BUY	$132.81 - $182.18 $318,744 - $437,232	2,400 New	2,400 $335,000
Q4 2020 Feb 11, 2021	SELL	$138.17 - $184.34 $303,974 - $405,548	-2,200 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$114.09 - $145.51 $250,998 - $320,122	2,200 New	2,200 $306,000

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $133M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.